Madison Reporter

Regarding the groundbreaking settlement in which the FDA has agreed to remove all consumer directives that discourage the use of ivermectin for COVID-19 prevention and treatment, Dr. Pierre Kory said that he  "extremely proud of our colleagues for taking a stand against a government health agency that is clearly overstepping its authority." Kory shared his comments in an interview with Madison Reporter last week. 

Representing three doctors in Apter v. Dep’t of Health and Human Services, Boyden Gray PLLC successfully challenged the FDA's overreach into the doctor-patient relationship.

Kory is the president of Front Line COVID-19 Critical Care Alliance (FLCCC), a 501(c)3 that recommends treating COVID-19 infection with alternative modalities, such as ivermectin and hydroxychloroquine.

“The FDA’s campaign against ivermectin caused many hospitals to restrict the use of the drug while some state medical boards threatened the licenses of doctors who prescribed a drug that had been proven to safely treat hundreds of thousands of patients in controlled trials around the world."

Dr. Paul E. Marik, a plaintiff in the case, emphasized the settlement's importance in safeguarding the doctor-patient relationship and preventing regulatory overreach by the FDA.

“Today’s settlement with the FDA is a major win for the doctor-patient relationship,” Marik said in a statement. “It vindicates our position that the FDA overstepped its regulatory authority by trying to dictate appropriate medical care.”

The lawsuit, initially dismissed but later revived by the U.S. Court of Appeals for the Fifth Circuit, alleged that the FDA overstepped its authority by discouraging ivermectin use.

The Fifth Circuit's previous ruling underscored the limitations of the FDA's authority in providing medical recommendations. 

FLCCC, which supported the plaintiffs via an amicus brief, earlier announced the settlement regarding the FDA's statements discouraging the use of ivermectin for COVID-19 prevention and treatment.

In the settlement, the FDA agreed to remove website and social media posts related to ivermectin use for COVID-19.

“Huge win for doctors and patients today. Americans should rejoice that we got the (P)FDA to get out of the practice of medicine. They knew they did not have that authority but did it anyway. Now they have to take everything they did against ivermectin off the internet," Kory said in response to Dr. Mary Talley Bowden's post on X. 

“FDA loses its war on ivermectin and agrees to remove all social media posts and consumer directives regarding ivermectin and COVID, including its most popular tweet in FDA history,” Bowden said on X.

Kory’s Substack sheds light on what he calls the "Horse Dewormer PR Campaign" in his book "The War on Ivermectin" in which he exposes coordinated efforts by various institutions to discredit ivermectin as an effective treatment for COVID-19.

The settlement marks a significant step in challenging the FDA's regulatory overreach and advocating for the rights of physicians to prescribe off-label medications.

Dr. Pierre Kory is the former chief of critical care at the University of Wisconsin Hospital. Kory also previously served as head of the main medical-surgical intensive care unit (ICU) at the university’s hospital.